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Medicare Part D Resources 
— Prepared from research by the editorial staff for subscribers of Pharmacist’s Letter and Prescriber’s Letter— 
For frequently asked Medicare Part D questions and answers, go to: 
http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg/php/enduser/std_alp.php and choose Prescription Drug Benefit from the 
category list to find specific questions and answers to Medicare Part D. 
 
The following resources are some of the numerous internet resource sites that may assist with patient and 
provider information. 
 
Patient Focused Resources 
 
American Association of 
Retired Persons (AARP) 
Identifies information Medicare beneficiaries should know, 
general costs, and what it means for the average couple. 
http://www.aarp.org/health/medicare/drug_coverage/a2004-03-
30-newdrugbenefit.html 
Center for Medicare 
Advocacy 
A Medicare advocacy organization offers information about 
Medicare Part D and provides weekly alerts on current topics. 
http://www.medicareadvocacy.org/ 
Centers for Medicare and 
Medicaid Services 
Information is available for health care consumers, including 
Medicare beneficiaries, Medicaid recipients, and others. 
http://www.cms.hhs.gov/default.asp?1=cons&2= 
Medicare Drug Benefit 
Calculator 
This calculator allows users to enter their prescription drug 
costs to determine what they will pay starting in 2006 under the 
Medicare prescription drug law. 
http://www.kaisernetwork.org/static/kncalc.cfm 
Medicare Today Medicare Today is a partnership of organizations representing 
seniors, patients, health care groups, employers, and others 
whose mission is to inform beneficiaries about Medicare Part D. 
http://www.medicaretoday.org/ 
Medicare: The Official U.S. 
Government Site for People 
with Medicare 
The official U.S. government site for Medicare recipient 
information spotlights updates and new developing topics. 
http://www.medicare.gov/ 
Social Security Online Social Security's site is to help the public understand how they 
may qualify and apply for Medicare Part D. 
http://www.ssa.gov/prescriptionhelp/ 
Provider Focused Resources 
 
American Pharmacists 
Association (APhA) 
The APhA Resources: Medicare website contains resources 
designed to help pharmacists gain an understanding of this 
complex law and provide tools to help them assist patients. 
http://www.aphanet.org/Content/NavigationMenu/AdvocacyON 
YourBehalf/APhAResourcesMedicare/default.htm 
(Detail-Document #210801:  Page 2 of 7) 
More. . . 
Copyright © 2005 by Therapeutic Research Center 
Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone:  209-472-2240 ~ Fax:  209-472-2249 
www.pharmacistsletter.com ~ www.prescribersletter.com  
Provider Focused Resources (continued) 
 
American Society of 
Consultant Pharmacists 
(ASCP) 
ASCP’s government affairs resource center provides 
information about Medicare Part D including information 
related to long term care provisions. 
http://www.ascp.com/public/ga/ 
American Society of Health-
System Pharmacists (ASHP) 
ASHP’s Medicare Modernization Act resource center provides 
general information about Medicare Part D and special 
information about medication therapy management aspects. The 
latest in policy, breaking news, and CMS rules analysis are 
included. 
http://www.ashp.org/medicare/ 
Center for Medicare 
Advocacy 
A Medicare advocacy organization offers information about 
Medicare Part D and frequently asked questions. 
http://www.medicareadvocacy.org/FAQ_PrescDrugs.htm 
Centers for Medicare and 
Medicaid Services: 
Pharmacy Information 
This site provides information specific to pharmacy on 
Medicare Part D.  
http://www.cms.hhs.gov/medicarereform/pharmacy/ 
Centers for Medicare and 
Medicaid Services: 
Professionals 
Information is available for a variety of professional audiences, 
including the medical community. 
http://www.cms.hhs.gov/?1=pros 
National Association of 
Chain Drug Stores 
(NACDS) 
The government affairs Medicare resource center provides 
general information on Medicare Part D and various briefings. 
http://www.nacds.org/wmspage.cfm?parm1=3407 
National Community 
Pharmacists Association 
(NCPA) 
NCPA’s Medicare Resource Center provides a number of tools 
to help assist community pharmacists in educating their patients 
about Medicare Part D. 
http://www.medicareresourcecenter.com/ 
National Plan and Provider 
Enumeration System 
(NPPES) 
NPPES  provides information about obtaining and applying for 
an National Provider Identifier number for individual provider 
billing for Medicare Part D medication therapy management 
services. 
https://nppes.cms.hhs.gov/NPPES/Welcome.do  
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New Medicare Part D Prescription Drug Information:  
Preparing for the Change 
Lead author: Joseph A. Woelfel, Ph.D., FASCP, R.Ph., Assistant Editor 
 
Background 
With the approval of the Medicare 
Modernization Act (MMA) in December 2003, a 
federal drug plan for seniors was created.  This 
new Medicare-sponsored drug plan, called 
Medicare Part D, will be instituted January 1, 
2006.  Numerous changes for eligible 
beneficiaries, their healthcare professionals, and 
prescription drug plan (PDP) providers will occur.  
Preparing for this major change is crucial.1   
Persons over age 65 or those permanently 
disabled can generally qualify for Part D.  Those 
currently entitled to Medicare Part A, which 
covers general hospitalization services, or enrolled 
in Medicare Part B, covering certain physician, 
outpatient hospital, home health, durable medical, 
or other services, or Medicare Part C (Medicare 
managed care plans or Medicare Advantage) will 
generally qualify.  Medicare patients receiving 
Medicaid (dual eligibility) will also have drug 
coverage under Medicare Part D.  They will be 
required to enroll in a Medicare Part D PDP or 
Medicare Advantage.  Enrollment will begin on 
November 15 and continue until May 31, 2006.  
To encourage timely participation, those who 
enroll after May 31, 2006 will be required to pay a 
late-enrollment penalty.1-4  
 
Timeline for Changes 
The following timeline may help provide a 
perspective of the changes and when they will 
occur: 
• September 14, 2005 - PDP provider-
awarded agreements to be tentatively 
announced by Centers for Medicare and 
Medicaid Services (CMS)  
• October 1 to 15, 2005 - CMS to mail 
informational booklet, “Medicare & You” 
to beneficiaries describing prescription 
plan benefit and cost information 
• October 1, 2005 - CMS-approved PDP 
providers to begin marketing their plans to 
beneficiaries 
• October 13, 2005 - CMS to distribute 
information comparing available Part D 
coverage to beneficiaries through the mail, 
CMS website, and by phone 
• November 15, 2005 - Beneficiary open 
enrollment begins for Medicare Part D 
• December 31, 2005 - Medicaid drug 
coverage ends for Medicare patients (dual 
eligibles) 
• December 31, 2005 - Medicare 
prescription drug discount card program to 
end (phase out period will extend until 
May 15, 2006) 
• January 1, 2006 – New Medicare Part D 
prescription drug plan starts5,6 
 
PDP Providers 
Prescription drug plans submitted by providers 
or sponsors are currently being evaluated by 
CMS.  The PDP and Medicare Advantage drug 
plan (MA-PD) providers will compete for three 
year contracts with CMS.  The PDP sponsors will 
use a typical fee-for-service plan and share 
financial risk for the benefits offered under the 
plan.  The PDP providers’ drug coverage 
provisions are similar to those currently 
administered by pharmacy benefits managers 
(PBMs).1-4   
They will have different formularies, 
pharmacy networks, beneficiary prescription fees, 
and pharmacy reimbursement provisions.  Each 
PDP provider is required by CMS to have a 
pharmacy and therapeutics committee, a cost and 
quality management program, and include 
medication therapy management (MTM) 
programs (MTMPs).  They are required to allow 
any pharmacy meeting their provider 
qualifications the ability to participate in their 
program.1-4  Several major insurance companies 
and PBMs have indicated their desire to 
participate as PDP providers.  Some of these are: 
Medco, Caremark, United Health, Prescription 
Solutions American Financial Services 
Group/CVS, Aetna, Blue Cross, and Wellpoint.   
CMS has defined 34 national geographic 
regions including some single state and multi-state 
regions.  Plan providers can offer services in any 
of the regions but they are not allowed to divide 
states.7   
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Just as with participation in a PBM or 
insurance drug plan, each pharmacy must 
carefully evaluate the benefits and economic 
impact (gross margin profitability) of 
participation.  Each pharmacy must also consider 
their patients’ current medication profiles and a 
matching PDP provider formulary.  Without this 
match, the patient may need to choose another 
pharmacy for his or her services. 
Once CMS has awarded PDP provider 
agreements, pharmacists and patients will be able 
to determine which provider plans to join.  CMS 
and others will provide web-based tools and other 
resources to guide in this determination.8-10  
 
Provider Formularies 
Provider formularies can vary with the plan 
sponsor.  CMS has defined Medicare Part D 
covered drugs as those that are dispensed only on 
prescription, biological products, certain vaccines, 
insulin, and insulin-associated medical supplies.  
Drugs restricted or excluded from Medicaid 
coverage are not included, with the exception of 
smoking cessation drugs.  Each formulary must 
include all therapeutic categories and classes of 
drugs but not necessarily all drugs within a 
category or class.  Plans will cover compounded 
prescription drugs if at least one of the 
compounded ingredients is a Medicare Part D 
covered drug.  The U.S. Pharmacopeia developed 
the list of categories and classes to be used by 
drug plan sponsors.9-11   
The following drugs are not covered under 
standard Part D plans: barbiturates, 
benzodiazepines, anorexia, weight loss, or weight 
gain products, fertility products, hair growth 
products, products for symptomatic relief of 
cough or cold, prescription vitamins or minerals, 
nonprescription drugs, and any drug covered by 
Medicare Part A or B.8-10  It should be noted that 
bipartisan legislation (H.R. 3151) was introduced 
that would remove the exclusion of 
benzodiazepines from the new Medicare Part D 
prescription drug benefit.12  
Beneficiaries will be able to appeal non-
formulary covered drugs when the drug is 
considered medically necessary for that 
individual.10 
 
Patient Considerations 
Patients will have a choice of at least two 
qualifying PDPs in their area, of which at least 
one is a drug-only plan, not an integrated MA-PD 
managed care plan.  Plan providers can market 
directly to beneficiaries using CMS-approved 
materials.  
To assure patient access to pharmacies, CMS 
has adopted the Department of Defense 
TRICARE Retail Pharmacy access standards 
applied on a state basis.  Plans must provide 
access to pharmacies within two miles in urban 
areas, five miles in suburban areas for 90% of 
enrollees, and 15 miles in rural areas for 70% of 
enrollees.  Mail order pharmacies may be used by 
patients but they cannot be the only pharmacy 
type accessible to the patient.  Furthermore, 
beneficiaries must be allowed emergency 
prescription access in a pharmacy not necessarily 
associated with a plan or network.  Patients in 
long-term care facilities will be assured access to 
pharmacies because PDP providers must offer a 
standard contract to all long-term care pharmacies 
in the plan’s service area.  CMS has established 
certain standard service and performance 
provisions for long term care pharmacies.4,9,10 
Plan costs to the patient have been established 
by CMS but will also depend on the costs dictated 
by the PDP provider.    
The standard benefit for those covered under 
Medicare Part A or B (excludes Medicare Part C 
Medicare Advantage participants) will be: 
• A $250 deductible 
• Part D drug expenses over $250 but less 
than $2,250 will require a 25% patient co-
pay 
• Part D drug expenses greater than $2,250 
up to $5,100 will be paid entirely by the 
patient (so called “doughnut hole”) 
• Part D drug expense over $5,100 will 
require a $2 co-pay for generic or 
preferred multi-source drugs or $5 or 5% 
co-pay, whichever is greater, up to $3,600 
• A monthly plan premium of $37 or less 
depending on the PDP will be charged.  
This premium may be deducted from a 
beneficiary’s monthly social security 
check, if desired.4,9,10 
Special or low income benefit groups will be 
identified by reference to the Federal poverty line 
for annual income.  Patients with incomes up to 
150% of the Federal poverty line will be provided 
subsidies for premiums and cost sharing.4,9,10
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Medicare Advantage participants will have 
benefits established through the Medicare 
Advantage drug plan (MA-PD) providers contract 
approved by CMS.  
Patients currently with both Medicaid and 
Medicare benefits (dual eligibles) must enroll in a 
PDP or a MA-PD, otherwise a PDP will be 
randomly assigned to them.  These beneficiaries 
will pay $1 for generic medications and $3 for 
brand-name drugs.9 
Patients can switch plans at their next annual 
coordinated enrollment period, however dual 
eligibles may “opt out” of a plan at any time. 
 
Pharmacy Considerations 
Pharmacies are free to contract with any PDP 
or MA-PD provider as long as they meet certain 
provider standards.  This qualified “at-will” 
contracting by the pharmacy ensures the ability to 
participate.  Plans can qualify a pharmacy as 
“preferred” or “non-preferred” based on the 
pharmacy’s service or other provisions.  Long 
term care pharmacies in a plan’s service area must 
be offered a standard contract as long as they meet 
CMS mandated service and performance 
standards.8-10   
Each pharmacy should evaluate participation 
in a PDP based on service to existing patients and 
gross profit margins offered by the plan.  Levels 
of reimbursement will be set by the PDP provider.  
Pharmacy reimbursement will be for dispensing 
fees or costs associated with the prescription’s 
provision to the patient.  Supply items such as 
drug, vial, label, as well as pharmacist and staff 
time, including pharmacist prescription 
consultation with the patient, are included.  
Services such as medication therapy management 
programs (MTMP) are excluded from this 
reimbursement.  These must be separately defined 
and billed by the pharmacy or pharmacist given 
the PDP providers’ defined MTMP provisions and 
requirements.4,8-10  
Community pharmacies will be able to offer an 
extended or 90-day supply of medications to 
beneficiaries.  This will “level the playing field” 
as an alternative to patient use of a mail-order 
pharmacy.8-10   
Plan beneficiaries will receive PDP sponsor 
identification cards as required by CMS.  All PDP 
sponsor cards will contain the same standard, 
required information.  Patient information card 
standardization is a long awaited benefit.4,8-10   
At this time, there is no requirement that 
prescriptions be transmitted electronically.  PDP 
providers are, however, required as of January 1, 
2006, to comply with CMS adopted National 
Council for Prescription Drug Program’s 
(NCPDP) SCRIPT Standard version 5.0 for 
transmitting prescription information and the 
NCPDP Telecommunication Standard Guide 
version 5.1 for transmitting eligibility and benefit 
information.10   
Once CMS has awarded the PDP provider 
contracts and beneficiaries have received program 
information, pharmacists will be sought by their 
Medicare patients for information and help in 
identifying “best fit" PDP provider programs.  
CMS and others will offer web-based tools and 
written information for helping with these 
decisions.  This should occur sometime in October 
2005.4,6,8-10 
As an essential and long-awaited part of 
Medicare Part D, MTMPs will begin on January 
1, 2006.  PDP providers will identify at-risk, high 
drug utilization patients, and others through their 
quality and cost management utilization reviews.  
These providers may seek the assistance of local 
network pharmacists within the pharmacy or 
independent consultant pharmacists for provision 
of these MTMPs.  PDP sponsors will establish 
independent fees and provide negotiated 
reimbursement for these services.8  Through the 
efforts of the Pharmacist Services Technical 
Advisory Coalition (PSTAC) codes for 
pharmacist billing of these services have been 
established.13  The American Medical Association 
Current Procedural Terminology (CPT) Editorial 
Panel has approved three codes for this purpose.  
The CPT codes and their uses are: 
• Code 0115T - a first-encounter face to face 
service performed with a patient in a time 
increment up to 15 minutes 
• Code 0116T - for use with the same patient 
in a time increment up to 15 minutes for a 
subsequent or follow-up encounter 
• Code +0117T – for billing additional 15 
minute increments of time to either of the 
preceding codes 
These codes become effective January 1, 
2006.13 
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Prescriber Considerations 
As of January 1, 2006 prescribers will be faced 
with new PDP provider formularies and formulary 
choices for patients.  Prior to that time, Medicare 
beneficiaries will seek their prescriber’s advice for 
identification of best PDP plans.  Again, CMS and 
others will offer web-based tools and written 
information for helping with these decisions.10   
PDP providers must be able to support 
electronic prescribing for those prescribers 
wishing to use this tool.10  
 
Commentary 
In the coming months, more information and 
helpful resources will become available from 
CMS as well as consumer and professional 
organizations.  This information will help with the 
difficult decisions of plan choice by both patients 
and practitioners. 
Please see the patient and provider resource 
guide in this document for helpful sites and 
sources of information. 
 
Glossary of Terms 
• CMS: Centers for Medicare and Medicaid 
Services  
• CPT: Current Procedural Terminology 
• MA-PD: Medicare Advantage drug plan  
• MMA: Medicare Modernization Act  
• Medicare Part A: coverage for general 
hospitalization services 
• Medicare Part B: coverage for certain 
physician, outpatient hospital, home health, 
durable medical, or other services 
• Medicare Part C: Medicare managed care 
plan or Medicare Advantage 
• Medicare Part D: Medicare-sponsored drug 
plan 
• MTMP, MTM, or MTMS: medication 
therapy management programs or services 
• PSTAC: Pharmacist Services Technical 
Advisory Coalition  
• NCPDP: National Council for Prescription 
Drug Programs  
• PBMs: pharmacy benefits managers  
• PDP: prescription drug plan 
• SCRIPT: standard created to facilitate the 
electronic transfer of prescription data 
between pharmacies and prescribers. 
• TRICARE: Department of Defense health 
care program for active duty and retired 
members of the uniformed services, their 
families, and survivors 
 
 
Users of this document are cautioned to use their own 
professional judgment and consult any other necessary 
or appropriate sources prior to making clinical 
judgments based on the content of this document.  Our 
editors have researched the information with input 
from experts, government agencies, and national 
organizations.  Information and Internet links in this 
article were current as of the date of publication. 
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